TAFAZZIN and Barth syndrome: In lymphoblast derived from BTHS patients, a MLCL/CL ratio was reported to be reduced by specific inhibition of these iPLA2s by bromoenol lactone (Malhotra et al, 2009a), suggesting a negative role of these iPLA2s together when tafazzin is deficient in lymphoblast.